Replication Data for: NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE-BASED CHEMORADIOTHERAPY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC CANCER (PREOPANC-2)

DOI

This dataset contains the replication data for the PREOPANC-2 trial.

The data are sensitive since they involve personal information of patients. There are restrictions on use by commercial parties and on sharing openly, based on (inter)national laws and regulations and written informed consent. Therefore these data (and additional clinical data) are only available upon signing a Data Transfer Agreement (see Terms of Access).

Identifier
DOI https://doi.org/10.34894/4PKDXN
Metadata Access https://dataverse.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.34894/4PKDXN
Provenance
Creator Backer - Janssen, Kiki (ORCID: q.janssen)
Publisher DataverseNL
Contributor Bas Groot Koerkamp; Backer - Janssen, Kiki; prof. dr. B. Groot Koerkamp; Dutch Pancreatic Cancer Group; Erasmus MC Cancer Institute
Publication Year 2025
Funding Reference ZonMW 843004108 ; KWF (Dutch Cancer Society) 109555
Rights info:eu-repo/semantics/openAccess
OpenAccess true
Contact Bas Groot Koerkamp (Erasmus MC); Backer - Janssen, Kiki (Erasmus MC)
Representation
Resource Type Clinical data; Dataset
Version 1.0
Discipline Life Sciences; Medicine
Spatial Coverage Erasmus MC Cancer Institute